THE LAW CENTER

Zantac – Liver Disease and Cancer

Zantac is one of the most popular over-the-counter medications in the country, with millions of people using it to relieve heartburn symptoms and chest pain. However, it’s also a potential cancer risk.

The U.S. Food and Drug Administration (FDA) announced a recall of Zantac along with all other medications using its active ingredient, Ranitidine. This recall follows new research that found that the Ranitidine used in medications like Zantac was too often contaminated by N-Nitrosodimethylamine (NDMA), a chemical classified as a probable carcinogen by the FDA, the Environmental Protection Agency, and the World Health Organization. According to the U.S. Centers for Disease Control (CDC), NDMA has been linked to a variety of diseases, including severe liver disease, liver cancer, testicular cancer, and lung cancer.

 

Millions of people used Zantac for years not knowing about the risks they were exposing themselves to, and some users are now suffering from cancer that may have been caused by the drug. Zantac’s manufacturer, Sanofi, had a responsibility to ensure that their customers wouldn’t suffer injury from using their product, and they have failed to meet that responsibility.

Zantac users who have suffered injury deserve compensation, and the law center wants to help them get it. If you or a loved one was diagnosed with cancer after using Zantac, click the “Request Consultation” button for a free case evaluation.